Baoping Cao

563 total citations
19 papers, 435 citations indexed

About

Baoping Cao is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Baoping Cao has authored 19 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Baoping Cao's work include Cancer-related gene regulation (12 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (3 papers). Baoping Cao is often cited by papers focused on Cancer-related gene regulation (12 papers), Epigenetics and DNA Methylation (11 papers) and RNA modifications and cancer (3 papers). Baoping Cao collaborates with scholars based in China, United States and Belgium. Baoping Cao's co-authors include Mingzhou Guo, James G. Herman, Shicheng Guo, Kai Ma, Yunsheng Yang, Malcolm V. Brock, Qimin Zhan, Meiying Zhang, Yan Jia and Enqiang Linghu and has published in prestigious journals such as Chemosphere, Oncotarget and Journal of Molecular Medicine.

In The Last Decade

Baoping Cao

18 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Baoping Cao China 13 327 117 78 64 53 19 435
Nadeem S. Bhat United States 14 337 1.0× 230 2.0× 126 1.6× 91 1.4× 104 2.0× 26 552
Katarzyna Kiwerska Poland 13 428 1.3× 166 1.4× 102 1.3× 34 0.5× 73 1.4× 35 558
Liping Nie China 10 383 1.2× 308 2.6× 86 1.1× 22 0.3× 41 0.8× 18 509
Y-W Cheng Taiwan 7 274 0.8× 117 1.0× 102 1.3× 12 0.2× 37 0.7× 7 355
Ge Yu China 10 275 0.8× 144 1.2× 103 1.3× 43 0.7× 55 1.0× 20 428
Kevin S. McDorman United States 7 153 0.5× 63 0.5× 94 1.2× 34 0.5× 42 0.8× 14 337
Xinkai Cao China 8 194 0.6× 233 2.0× 85 1.1× 26 0.4× 71 1.3× 10 376
Santiyagu M. Savarimuthu Francis Australia 9 145 0.4× 95 0.8× 71 0.9× 18 0.3× 153 2.9× 15 339

Countries citing papers authored by Baoping Cao

Since Specialization
Citations

This map shows the geographic impact of Baoping Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baoping Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baoping Cao more than expected).

Fields of papers citing papers by Baoping Cao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baoping Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baoping Cao. The network helps show where Baoping Cao may publish in the future.

Co-authorship network of co-authors of Baoping Cao

This figure shows the co-authorship network connecting the top 25 collaborators of Baoping Cao. A scholar is included among the top collaborators of Baoping Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baoping Cao. Baoping Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Jin, Meiling, et al.. (2023). Integrative analysis of the association between circadian rhythm and lupus nephritis. Clinical Kidney Journal. 16(9). 1489–1499. 1 indexed citations
2.
Zhong, Kaili, Baoping Cao, Xiaochuan Guo, et al.. (2022). [Clinical Characteristics and Long-term Prognosis Analysis of Patients with Primary Bone Lymphoma].. PubMed. 30(1). 126–130. 1 indexed citations
3.
Cao, Baoping, Xiaochuan Guo, Bin Wang, et al.. (2022). Hypomethylation and the Resultant Overexpressed PARM1: a Biomarker for Poor Prognosis of Diffuse Large B-cell Lymphoma.. PubMed. 33(168). 27–40.
4.
Zheng, Rui, Pengju Wang, Baoping Cao, et al.. (2021). Intestinal response characteristic and potential microbial dysbiosis in digestive tract of Bufo gargarizans after exposure to cadmium and lead, alone or combined. Chemosphere. 271. 129511–129511. 39 indexed citations
5.
Cao, Baoping, Xiaochuan Guo, Bin Wang, et al.. (2021). Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma. Aging. 13(13). 17768–17788. 8 indexed citations
6.
Gao, Weibo, et al.. (2019). The effect of hypertension on the prognosis of acute aortic dissection. Zhonghua jizhen yixue zazhi. 28(5). 614–618. 1 indexed citations
7.
Lin, Shuye, Xiaoyue Wang, Meiying Zhang, et al.. (2017). Epigenetic silencing of PRSS3 provides growth and metastasis advantage for human hepatocellular carcinoma. Journal of Molecular Medicine. 95(11). 1237–1249. 14 indexed citations
8.
Cao, Baoping, Weili Yang, Meiying Zhang, et al.. (2016). Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling. Journal of Thoracic Oncology. 11(11). 1912–1926. 31 indexed citations
9.
Ma, Kai, Baoping Cao, & Shicheng Guo. (2016). The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma. Clinical Epigenetics. 8(1). 43–43. 77 indexed citations
10.
Zhang, Meiying, Enqiang Linghu, Qimin Zhan, et al.. (2016). Methylation ofDACT2accelerates esophageal cancer development by activating Wnt signaling. Oncotarget. 7(14). 17957–17969. 25 indexed citations
11.
Cao, Baoping, Meiying Zhang, Chao Di, et al.. (2016). Systematic study of novel lncRNAs in different gastrointestinal cancer cells.. PubMed. 21(115). 159–71. 9 indexed citations
12.
Cao, Baoping, Meiying Zhang, Enqiang Linghu, et al.. (2015). Epigenetic silencing BCL6B induced colorectal cancer proliferation and metastasis by inhibiting P53 signaling.. PubMed. 5(2). 651–62. 23 indexed citations
13.
Dong, Yan, Baoping Cao, Meiying Zhang, et al.. (2015). Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growth. Oncotarget. 6(26). 22126–22138. 31 indexed citations
14.
Cao, Baoping, Meiying Zhang, Qimin Zhan, et al.. (2015). RASSF10 suppresses hepatocellular carcinoma growth by activating P53 signaling and methylation of RASSF10 is a docetaxel resistant marker. Genes & Cancer. 6(5-6). 231–240. 17 indexed citations
15.
Jia, Yan, Baoping Cao, Yunsheng Yang, et al.. (2015). Silencing NKD2 by promoter region hypermethylation promotes gastric cancer invasion and metastasis by up-regulating SOX18 in human gastric cancer. Oncotarget. 6(32). 33470–33485. 29 indexed citations
16.
Yan, Wenji, Xuefeng Liu, Yan Jia, et al.. (2014). DACT2 is frequently methylated in human gastric cancer and methylation of DACT2 activated Wnt signaling.. PubMed. 4(6). 710–24. 36 indexed citations
17.
Cao, Baoping, Yunsheng Yang, Yuanming Pan, et al.. (2013). Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.. PubMed. 16(88). 137–47. 39 indexed citations
18.
Jia, Yan, Yunsheng Yang, Malcolm V. Brock, et al.. (2012). Methylation of TFPI-2 is an Early Event of Esophageal Carcinogenesis. Epigenomics. 4(2). 135–146. 36 indexed citations
19.
Hoque, Mohammad Obaidul, et al.. (2011). AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. Tumor Biology. 33(2). 307–314. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026